According to a recently released Fact.MR study, revenues from dyslipidemia therapeutics market surpassed US$ 36 billion in 2018. Low-density lipoproteins held approximately two-thirds of revenues from [read full press release…]
Rockville, USA, 2019-May-08 — /EPR Network/ — A recently compiled Fact.MR report, titled “Dyslipidemia Therapeutics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2018-2028” [read full press release…]
Rockville, USA, 2019-Apr-01 — /EPR Network/ — A recently compiled Fact.MR report, titled “Dyslipidemia Therapeutics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2018-2028” [read full press release…]
